Bayer Corp. says a recent study provides additional support for the cardiovascular safety of over-the-counter doses of naproxen sodium. The data was presented at a recent meeting of the American College of Rheumatology. Bayer markets the Aleve brand name of naproxen sodium as a nonprescription product. hoodia.
Related Results
ACR white paper to address use of naproxen, aspirinVioxx label now says it's riskier than naproxenNaproxen debutNaproxen Versus RofecoxibFDA statement on Naproxen.
COPYRIGHT 2006 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning